A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's disease.
Johnson AM, Askar M, Belani S, Khan A, Xu AA, Kassmeyer B, Said H, Santiago-Castro M, Devi J, Huang K, Jaiprada F, Seth N, Dulaney D, Loftus EV Jr, Fenster M, Patel A, Bishu S, Ungaro RC, Shukla R, Yarur AJ, Deepak P.
Johnson AM, et al. Among authors: devi j.
J Crohns Colitis. 2025 May 8;19(5):jjaf070. doi: 10.1093/ecco-jcc/jjaf070.
J Crohns Colitis. 2025.
PMID: 40289770